Cogent Biosciences, Inc. (COGT) vs CRISPR Therapeutics AG (CRSP)
A side-by-side comparison of Cogent Biosciences, Inc. and CRISPR Therapeutics AG across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COGT
Cogent Biosciences, Inc.
$30.74HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
CRSP
CRISPR Therapeutics AG
$54.53HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
Total return — COGT vs CRSP
growth of $100 · dividends reinvested · last 9yCOGT -30.5% (-4.0%/yr)CRSP +28.3% (+2.8%/yr)CRSP compounded faster over this window
COGT CRSP
COGT vs CRSP: by the numbers
- •CRSP is the larger company ($5.26B vs $5.25B market cap).
- •Both run net losses; COGT's is the smaller (0.00% vs -3368.72% net margin).
Metrics side by side
Valuation
| Metric | COGT | CRSP |
|---|---|---|
| P/S ratio | N/A | 392.72 |
| P/B ratio | 11.23 | 3.01 |
Profitability
| Metric | COGT | CRSP |
|---|---|---|
| Gross margin | 0.00% | -6537.01% |
| Operating margin | 0.00% | -16191.40% |
| Net margin | 0.00% | -3368.72% |
| ROE | -70.85% | -25.83% |
| ROIC | -50.09% | -21.12% |
Growth (annualized)
| Metric | COGT | CRSP |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 37.32% |
| Total return CAGR (5Y) | 28.51% | -10.97% |
Frequently asked
- How have COGT and CRSP total returns compared?
- Over the past 5 years, COGT delivered 28.51% and CRSP delivered -10.97% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cogent Biosciences ROECRISPR Therapeutics AG ROECogent Biosciences operating marginCRISPR Therapeutics AG operating marginCogent Biosciences revenue growthCRISPR Therapeutics AG revenue growthCogent Biosciences free cash flowCRISPR Therapeutics AG free cash flow
Cogent Biosciences & CRISPR Therapeutics AG appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.